Repository logo
Communities & Collections
All of UMU-IR
  • English
  • العربية
  • বাংলা
  • Català
  • Čeština
  • Deutsch
  • Ελληνικά
  • Español
  • Suomi
  • Français
  • Gàidhlig
  • हिंदी
  • Magyar
  • Italiano
  • Қазақ
  • Latviešu
  • Nederlands
  • Polski
  • Português
  • Português do Brasil
  • Srpski (lat)
  • Српски
  • Svenska
  • Türkçe
  • Yкраї́нська
  • Tiếng Việt
Log In
New user? Click here to register. Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Atong Abraham"

Filter results by typing the first few letters
Now showing 1 - 1 of 1
  • Results Per Page
  • Sort Options
  • No Thumbnail Available
    Item
    Prevalence and clinical correlates of antiseizuremedication polytherapy among children andadolescents attending a specialist paediatricneurology clinic in Uganda
    (Research Square, 2026-10-05) Atong Abraham; Owiny Augustine Okejomoe; Namisi Patrick Charles; Sebunya Robert
    Background Antiseizure medication (ASM) monotherapy is generally preferred for childhood epilepsy, but somechildren require two or more ASMs because of persistent seizures, epilepsy syndrome, treatmenttransition or greater clinical complexity. Contemporary Ugandan data on the frequency and clinicalcorrelates of paediatric ASM polytherapy are limited. Objective To determine the prevalence of current ASM polytherapy and identify clinical factors associated withpolytherapy among children and adolescents attending a specialist paediatric neurology clinic inUganda. Methods We conducted a cross-sectional analysis of retrospectively abstracted clinical data from 496 childrenand adolescents aged 1–18 years with epilepsy attending the Paediatric Neurology Clinic at St. FrancisHospital Nsambya, Kampala, Uganda. Current ASM regimen was classified as monotherapy orpolytherapy. Modified Poisson regression with robust standard errors was used to estimate crude andadjusted prevalence ratios (PRs) with 95% confidence intervals (CIs). Results Seventy-eight of 496 participants were recorded as receiving polytherapy, giving a prevalence of 15.7%(95% CI 12.8–19.2). In the primary adjusted model, generalized epilepsy was associated with a higherprevalence of recorded polytherapy than focal epilepsy (aPR 2.62, 95% CI 1.70–4.04; p < 0.001), whileany documented comorbid condition was associated with approximately twice the prevalence (aPR 2.01,95% CI 1.25–3.23; p = 0.004). Medication-name review classified 64/496 (12.9%) as receiving at leasttwo recognizable ASMs; agreement with the recorded regimen classification was 92.7% (Cohen's kappa0.70). In this sensitivity analysis, the association with comorbidity remained strong (aPR 2.65; p < 0.001),whereas the generalized-epilepsy association attenuated to borderline statistical significance (aPR 1.60;p = 0.050). Conclusion Approximately one in six children and adolescents were recorded as receiving ASM polytherapy.Comorbidity was the most robust clinical correlate across outcome definitions. The association with generalized epilepsy was sensitive to how polytherapy was classified, highlighting the importance ofstandardized medication reconciliation in retrospective epilepsy research.

Uganda Martyrs University copyright ©2026 LYRASIS

  • Privacy policy
  • End User Agreement
  • Send Feedback